Selected research
Market Outlook & Growth Opportunities
Global Drug Residue Testing Solution Market Outlook and Growth Opportunities 2026
Market perspective
The global Drug Residue Testing Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Drug Residue Testing Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Drug Residue Testing Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Drug Residue Testing Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Drug Residue Testing Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Drug Residue Testing Solution market include FOSS, Bulteh 2000, Scope Electric, DSM, PerkinElmer, Charm Sciences, Chr. Hansen Holding, Bioeasy and Lactotronic, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Drug Residue Testing Solution market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Drug Residue Testing Solution and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Drug Residue Testing Solution revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Drug Residue Testing Solution market.
Drug Residue Testing Solution Segment by Company
FOSS
Bulteh 2000
Scope Electric
DSM
PerkinElmer
Charm Sciences
Chr. Hansen Holding
Bioeasy
Lactotronic
Specac
Florecers
Polymer Testing Lab
Cambrex
CTI
Drug Residue Testing Solution Segment by Type
Gas Chromatography
Liquid Chromatography
Others
Drug Residue Testing Solution Segment by Application
Food and Beverage
Vegetables and Fruits
Meat Products
Others
Drug Residue Testing Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Drug Residue Testing Solution status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Drug Residue Testing Solution key companies, revenue, market share, and recent developments.
3. To split the Drug Residue Testing Solution breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Drug Residue Testing Solution market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Drug Residue Testing Solution significant trends, drivers, influence factors in global and regions.
6. To analyze Drug Residue Testing Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Residue Testing Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Residue Testing Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Residue Testing Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Residue Testing Solution industry.
Chapter 3: Detailed analysis of Drug Residue Testing Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Drug Residue Testing Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Drug Residue Testing Solution in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Drug Residue Testing Solution Industry Trends
Table 2. Drug Residue Testing Solution Industry Drivers
Table 3. Drug Residue Testing Solution Industry Opportunities and Challenges
Table 4. Drug Residue Testing Solution Industry Restraints
Table 5. Global Drug Residue Testing Solution Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Drug Residue Testing Solution Revenue Share by Company (2021-2026)
Table 7. Global Drug Residue Testing Solution Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Drug Residue Testing Solution Key Company Manufacturing Base & Headquarters
Table 9. Global Drug Residue Testing Solution Company, Product Type & Application
Table 10. Global Drug Residue Testing Solution Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Drug Residue Testing Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Gas Chromatography
Table 15. Significant Companies of Liquid Chromatography
Table 16. Significant Companies of Others
Table 17. Global Drug Residue Testing Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 18. Global Drug Residue Testing Solution Sales Value by Type (2021-2026) & (US$ Million)
Table 19. Global Drug Residue Testing Solution Sales Value by Type (2027-2032) & (US$ Million)
Table 20. Global Drug Residue Testing Solution Sales Value Share by Type (2021-2026)
Table 21. Global Drug Residue Testing Solution Sales Value Share by Type (2027-2032)
Table 22. Significant Companies of Food and Beverage
Table 23. Significant Companies of Vegetables and Fruits
Table 24. Significant Companies of Meat Products
Table 25. Significant Companies of Others
Table 26. Global Drug Residue Testing Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 27. Global Drug Residue Testing Solution Sales Value by Application (2021-2026) & (US$ Million)
Table 28. Global Drug Residue Testing Solution Sales Value by Application (2027-2032) & (US$ Million)
Table 29. Global Drug Residue Testing Solution Sales Value Share by Application (2021-2026)
Table 30. Global Drug Residue Testing Solution Sales Value Share by Application (2027-2032)
Table 31. Global Drug Residue Testing Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 32. Global Drug Residue Testing Solution Sales Value by Region (2021-2026) & (US$ Million)
Table 33. Global Drug Residue Testing Solution Sales Value Share by Region (2021-2026)
Table 34. Global Drug Residue Testing Solution Sales Value by Region (2027-2032) & (US$ Million)
Table 35. Global Drug Residue Testing Solution Sales Value Share by Region (2027-2032)
Table 36. Global Drug Residue Testing Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Global Drug Residue Testing Solution Sales Value by Country (2021-2026) & (US$ Million)
Table 38. Global Drug Residue Testing Solution Sales Value Market Share by Country (2021-2026)
Table 39. Global Drug Residue Testing Solution Sales Value by Country (2027-2032) & (US$ Million)
Table 40. Global Drug Residue Testing Solution Sales Value Market Share by Country (2027-2032)
Table 41. FOSS Company Information
Table 42. FOSS Business Overview
Table 43. FOSS Drug Residue Testing Solution Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. FOSS Drug Residue Testing Solution Product Portfolio
Table 45. FOSS Recent Development
Table 46. Bulteh 2000 Company Information
Table 47. Bulteh 2000 Business Overview
Table 48. Bulteh 2000 Drug Residue Testing Solution Revenue (US$ Million) and Gross Margin (2021-2026)
Table 49. Bulteh 2000 Drug Residue Testing Solution Product Portfolio
Table 50. Bulteh 2000 Recent Development
Table 51. Scope Electric Company Information
Table 52. Scope Electric Business Overview
Table 53. Scope Electric Drug Residue Testing Solution Revenue (US$ Million) and Gross Margin (2021-2026)
Table 54. Scope Electric Drug Residue Testing Solution Product Portfolio
Table 55. Scope Electric Recent Development
Table 56. DSM Company Information
Table 57. DSM Business Overview
Table 58. DSM Drug Residue Testing Solution Revenue (US$ Million) and Gross Margin (2021-2026)
Table 59. DSM Drug Residue Testing Solution Product Portfolio
Table 60. DSM Recent Development
Table 61. PerkinElmer Company Information
Table 62. PerkinElmer Business Overview
Table 63. PerkinElmer Drug Residue Testing Solution Revenue (US$ Million) and Gross Margin (2021-2026)
Table 64. PerkinElmer Drug Residue Testing Solution Product Portfolio
Table 65. PerkinElmer Recent Development
Table 66. Charm Sciences Company Information
Table 67. Charm Sciences Business Overview
Table 68. Charm Sciences Drug Residue Testing Solution Revenue (US$ Million) and Gross Margin (2021-2026)
Table 69. Charm Sciences Drug Residue Testing Solution Product Portfolio
Table 70. Charm Sciences Recent Development
Table 71. Chr. Hansen Holding Company Information
Table 72. Chr. Hansen Holding Business Overview
Table 73. Chr. Hansen Holding Drug Residue Testing Solution Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. Chr. Hansen Holding Drug Residue Testing Solution Product Portfolio
Table 75. Chr. Hansen Holding Recent Development
Table 76. Bioeasy Company Information
Table 77. Bioeasy Business Overview
Table 78. Bioeasy Drug Residue Testing Solution Revenue (US$ Million) and Gross Margin (2021-2026)
Table 79. Bioeasy Drug Residue Testing Solution Product Portfolio
Table 80. Bioeasy Recent Development
Table 81. Lactotronic Company Information
Table 82. Lactotronic Business Overview
Table 83. Lactotronic Drug Residue Testing Solution Revenue (US$ Million) and Gross Margin (2021-2026)
Table 84. Lactotronic Drug Residue Testing Solution Product Portfolio
Table 85. Lactotronic Recent Development
Table 86. Specac Company Information
Table 87. Specac Business Overview
Table 88. Specac Drug Residue Testing Solution Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. Specac Drug Residue Testing Solution Product Portfolio
Table 90. Specac Recent Development
Table 91. Florecers Company Information
Table 92. Florecers Business Overview
Table 93. Florecers Drug Residue Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 94. Florecers Drug Residue Testing Solution Product Portfolio
Table 95. Florecers Recent Development
Table 96. Polymer Testing Lab Company Information
Table 97. Polymer Testing Lab Business Overview
Table 98. Polymer Testing Lab Drug Residue Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 99. Polymer Testing Lab Drug Residue Testing Solution Product Portfolio
Table 100. Polymer Testing Lab Recent Development
Table 101. Cambrex Company Information
Table 102. Cambrex Business Overview
Table 103. Cambrex Drug Residue Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 104. Cambrex Drug Residue Testing Solution Product Portfolio
Table 105. Cambrex Recent Development
Table 106. CTI Company Information
Table 107. CTI Business Overview
Table 108. CTI Drug Residue Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 109. CTI Drug Residue Testing Solution Product Portfolio
Table 110. CTI Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Authors List of This Report
Table 113. Secondary Sources
Table 114. Primary Sources
List of Figures
Figure 1. Drug Residue Testing Solution Product Image
Figure 2. Global Drug Residue Testing Solution Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Drug Residue Testing Solution Market Size (2021-2032) & (US$ Million)
Figure 4. Global Drug Residue Testing Solution Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Gas Chromatography Image
Figure 8. Liquid Chromatography Image
Figure 9. Others Image
Figure 10. Global Drug Residue Testing Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Drug Residue Testing Solution Sales Value Share 2021 VS 2025 VS 2032
Figure 12. Global Drug Residue Testing Solution Sales Value Share by Type (2021-2032)
Figure 13. Food and Beverage Image
Figure 14. Vegetables and Fruits Image
Figure 15. Meat Products Image
Figure 16. Others Image
Figure 17. Global Drug Residue Testing Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 18. Global Drug Residue Testing Solution Sales Value Share 2021 VS 2025 VS 2032
Figure 19. Global Drug Residue Testing Solution Sales Value Share by Application (2021-2032)
Figure 20. Global Drug Residue Testing Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 21. Global Drug Residue Testing Solution Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 22. North America Drug Residue Testing Solution Sales Value (2021-2032) & (US$ Million)
Figure 23. North America Drug Residue Testing Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 24. Europe Drug Residue Testing Solution Sales Value (2021-2032) & (US$ Million)
Figure 25. Europe Drug Residue Testing Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 26. Asia-Pacific Drug Residue Testing Solution Sales Value (2021-2032) & (US$ Million)
Figure 27. Asia-Pacific Drug Residue Testing Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 28. South America Drug Residue Testing Solution Sales Value (2021-2032) & (US$ Million)
Figure 29. South America Drug Residue Testing Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 30. Middle East & Africa Drug Residue Testing Solution Sales Value (2021-2032) & (US$ Million)
Figure 31. Middle East & Africa Drug Residue Testing Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 32. USA Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 33. USA Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 34. USA Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 35. Canada Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 36. Canada Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 37. Canada Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 38. Mexico Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 39. Mexico Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 40. Mexico Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 41. Germany Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 42. Germany Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 43. Germany Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 44. France Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 45. France Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 46. France Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 47. U.K. Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 48. U.K. Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 49. U.K. Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 50. Italy Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 51. Italy Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 52. Italy Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 53. Spain Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 54. Spain Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 55. Spain Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 56. Russia Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 57. Russia Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 58. Russia Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 59. Netherlands Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 60. Netherlands Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 61. Netherlands Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 62. Nordic Countries Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 63. Nordic Countries Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 64. Nordic Countries Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 65. China Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 66. China Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 67. China Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 68. Japan Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 69. Japan Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 70. Japan Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 71. South Korea Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 72. South Korea Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 73. South Korea Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 74. India Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 75. India Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 76. India Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 77. Australia Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 78. Australia Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 79. Australia Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 80. Southeast Asia Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 81. Southeast Asia Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 82. Southeast Asia Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 83. Brazil Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 84. Brazil Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 85. Brazil Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 86. Argentina Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 87. Argentina Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 88. Argentina Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 89. Chile Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 90. Chile Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 91. Chile Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 92. Colombia Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 93. Colombia Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 94. Colombia Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 95. Peru Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 96. Peru Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 97. Peru Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 98. Saudi Arabia Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 99. Saudi Arabia Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 100. Saudi Arabia Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 101. Israel Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 102. Israel Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 103. Israel Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 104. UAE Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 105. UAE Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 106. UAE Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 107. Turkey Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 108. Turkey Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 109. Turkey Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 110. Iran Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 111. Iran Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 112. Iran Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 113. Egypt Drug Residue Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 114. Egypt Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 115. Egypt Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 116. Years Considered
Figure 117. Research Process
Figure 118. Key Executives Interviewed
Scope & coverage.
Types
- Gas Chromatography
- Liquid Chromatography
- Others
Applications
- Food and Beverage
- Vegetables and Fruits
- Meat Products
- Others
Companies covered
- FOSS
- Bulteh 2000
- Scope Electric
- DSM
- PerkinElmer
- Charm Sciences
- Chr. Hansen Holding
- Bioeasy
- Lactotronic
- Specac
- Florecers
- Polymer Testing Lab
- Cambrex
- CTI
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Drug Residue Testing Solution Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Drug Residue Testing Solution Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Drug Residue Testing Solution Market Dynamics
- 2.1 Drug Residue Testing Solution Industry Trends
- 2.2 Drug Residue Testing Solution Industry Drivers
- 2.3 Drug Residue Testing Solution Industry Opportunities and Challenges
- 2.4 Drug Residue Testing Solution Industry Restraints
3 Drug Residue Testing Solution Market by Company
- 3.1 Global Drug Residue Testing Solution Company Revenue Ranking in 2025
- 3.2 Global Drug Residue Testing Solution Revenue by Company (2021-2026)
- 3.3 Global Drug Residue Testing Solution Company Ranking (2024-2026)
- 3.4 Global Drug Residue Testing Solution Company Manufacturing Base and Headquarters
- 3.5 Global Drug Residue Testing Solution Company Product Type and Application
- 3.6 Global Drug Residue Testing Solution Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Drug Residue Testing Solution Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Drug Residue Testing Solution Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Drug Residue Testing Solution Market by Type
- 4.1 Drug Residue Testing Solution Type Introduction
- 4.1.1 Gas Chromatography
- 4.1.2 Liquid Chromatography
- 4.1.3 Others
- 4.2 Global Drug Residue Testing Solution Sales Value by Type
- 4.2.1 Global Drug Residue Testing Solution Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Drug Residue Testing Solution Sales Value by Type (2021-2032)
- 4.2.3 Global Drug Residue Testing Solution Sales Value Share by Type (2021-2032)
5 Drug Residue Testing Solution Market by Application
- 5.1 Drug Residue Testing Solution Application Introduction
- 5.1.1 Food and Beverage
- 5.1.2 Vegetables and Fruits
- 5.1.3 Meat Products
- 5.1.4 Others
- 5.2 Global Drug Residue Testing Solution Sales Value by Application
- 5.2.1 Global Drug Residue Testing Solution Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Drug Residue Testing Solution Sales Value by Application (2021-2032)
- 5.2.3 Global Drug Residue Testing Solution Sales Value Share by Application (2021-2032)
6 Drug Residue Testing Solution Regional Value Analysis
- 6.1 Global Drug Residue Testing Solution Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Drug Residue Testing Solution Sales Value by Region (2021-2032)
- 6.2.1 Global Drug Residue Testing Solution Sales Value by Region: 2021-2026
- 6.2.2 Global Drug Residue Testing Solution Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Drug Residue Testing Solution Sales Value (2021-2032)
- 6.3.2 North America Drug Residue Testing Solution Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Drug Residue Testing Solution Sales Value (2021-2032)
- 6.4.2 Europe Drug Residue Testing Solution Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Drug Residue Testing Solution Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Drug Residue Testing Solution Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Drug Residue Testing Solution Sales Value (2021-2032)
- 6.6.2 South America Drug Residue Testing Solution Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Drug Residue Testing Solution Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Drug Residue Testing Solution Sales Value Share by Country, 2025 VS 2032
7 Drug Residue Testing Solution Country-level Value Analysis
- 7.1 Global Drug Residue Testing Solution Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Drug Residue Testing Solution Sales Value by Country (2021-2032)
- 7.2.1 Global Drug Residue Testing Solution Sales Value by Country (2021-2026)
- 7.2.2 Global Drug Residue Testing Solution Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.7.2 France Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.14.2 China Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.17.2 India Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Drug Residue Testing Solution Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Drug Residue Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Drug Residue Testing Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 FOSS
- 8.1.1 FOSS Company Information
- 8.1.2 FOSS Business Overview
- 8.1.3 FOSS Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.1.4 FOSS Drug Residue Testing Solution Product Portfolio
- 8.1.5 FOSS Recent Developments
- 8.2 Bulteh 2000
- 8.2.1 Bulteh 2000 Company Information
- 8.2.2 Bulteh 2000 Business Overview
- 8.2.3 Bulteh 2000 Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.2.4 Bulteh 2000 Drug Residue Testing Solution Product Portfolio
- 8.2.5 Bulteh 2000 Recent Developments
- 8.3 Scope Electric
- 8.3.1 Scope Electric Company Information
- 8.3.2 Scope Electric Business Overview
- 8.3.3 Scope Electric Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.3.4 Scope Electric Drug Residue Testing Solution Product Portfolio
- 8.3.5 Scope Electric Recent Developments
- 8.4 DSM
- 8.4.1 DSM Company Information
- 8.4.2 DSM Business Overview
- 8.4.3 DSM Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.4.4 DSM Drug Residue Testing Solution Product Portfolio
- 8.4.5 DSM Recent Developments
- 8.5 PerkinElmer
- 8.5.1 PerkinElmer Company Information
- 8.5.2 PerkinElmer Business Overview
- 8.5.3 PerkinElmer Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.5.4 PerkinElmer Drug Residue Testing Solution Product Portfolio
- 8.5.5 PerkinElmer Recent Developments
- 8.6 Charm Sciences
- 8.6.1 Charm Sciences Company Information
- 8.6.2 Charm Sciences Business Overview
- 8.6.3 Charm Sciences Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.6.4 Charm Sciences Drug Residue Testing Solution Product Portfolio
- 8.6.5 Charm Sciences Recent Developments
- 8.7 Chr. Hansen Holding
- 8.7.1 Chr. Hansen Holding Company Information
- 8.7.2 Chr. Hansen Holding Business Overview
- 8.7.3 Chr. Hansen Holding Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.7.4 Chr. Hansen Holding Drug Residue Testing Solution Product Portfolio
- 8.7.5 Chr. Hansen Holding Recent Developments
- 8.8 Bioeasy
- 8.8.1 Bioeasy Company Information
- 8.8.2 Bioeasy Business Overview
- 8.8.3 Bioeasy Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.8.4 Bioeasy Drug Residue Testing Solution Product Portfolio
- 8.8.5 Bioeasy Recent Developments
- 8.9 Lactotronic
- 8.9.1 Lactotronic Company Information
- 8.9.2 Lactotronic Business Overview
- 8.9.3 Lactotronic Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.9.4 Lactotronic Drug Residue Testing Solution Product Portfolio
- 8.9.5 Lactotronic Recent Developments
- 8.10 Specac
- 8.10.1 Specac Company Information
- 8.10.2 Specac Business Overview
- 8.10.3 Specac Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.10.4 Specac Drug Residue Testing Solution Product Portfolio
- 8.10.5 Specac Recent Developments
- 8.11 Florecers
- 8.11.1 Florecers Company Information
- 8.11.2 Florecers Business Overview
- 8.11.3 Florecers Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.11.4 Florecers Drug Residue Testing Solution Product Portfolio
- 8.11.5 Florecers Recent Developments
- 8.12 Polymer Testing Lab
- 8.12.1 Polymer Testing Lab Company Information
- 8.12.2 Polymer Testing Lab Business Overview
- 8.12.3 Polymer Testing Lab Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.12.4 Polymer Testing Lab Drug Residue Testing Solution Product Portfolio
- 8.12.5 Polymer Testing Lab Recent Developments
- 8.13 Cambrex
- 8.13.1 Cambrex Company Information
- 8.13.2 Cambrex Business Overview
- 8.13.3 Cambrex Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.13.4 Cambrex Drug Residue Testing Solution Product Portfolio
- 8.13.5 Cambrex Recent Developments
- 8.14 CTI
- 8.14.1 CTI Company Information
- 8.14.2 CTI Business Overview
- 8.14.3 CTI Drug Residue Testing Solution Revenue and Gross Margin (2021-2026)
- 8.14.4 CTI Drug Residue Testing Solution Product Portfolio
- 8.14.5 CTI Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst